About Evidation
Evidation is a company based in Menlo Park (United States) founded in 2012 by Alessio Signorini. It operates as a Data-as-a-Service and Professional Services. Evidation has raised $259.16 million across 7 funding rounds from investors including McKesson, General Electric and Revelation Partners. Evidation offers products and services including Real-World Data Platform and Patient Insights. Evidation operates in a competitive market with competitors including myTomorrows, Antidote, Dyania Health, SubjectWell and Belong, among others.
- Headquarter Menlo Park, United States
- Founders Alessio Signorini
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Evidation Health, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$259.16 M (USD)
in 7 rounds
-
Latest Funding Round
$153 M (USD), Series E
Mar 22, 2021
-
Investors
McKesson
& 13 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Evidation
Evidation offers a comprehensive portfolio of products and services, including Real-World Data Platform and Patient Insights.
Real-world health data is collected for research purposes.
Patient experiences are analyzed for health outcome improvements.
People of Evidation
Unlock access to complete
Unlock access to complete
Funding Insights of Evidation
Evidation has successfully raised a total of $259.16M across 7 strategic funding rounds. The most recent funding activity was a Series E round of $153 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Evidation
Evidation has secured backing from 14 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include McKesson, General Electric and Revelation Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multistage investments are directed toward technology, healthcare, and climate sectors.
|
Locked | Locked | Locked | |
|
Private equity investments are managed for municipal pension plans.
|
Locked | Locked | Locked | |
|
Life sciences and tech focused impact VC firm funding companies in the US, the UK and Canada
|
Locked | Locked | Locked |
Investor details for Evidation
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Evidation
Investment portfolio details for Evidation
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Evidation
Detailed financials for Evidation
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Evidation Comparisons
Peer comparison for Evidation
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Evidation
Evidation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as myTomorrows, Antidote, Dyania Health, SubjectWell and Belong, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Platform provides access to drugs in development to patients and physicians
|
|
| Locked | Locked | Locked |
Provider of search engine tool for patients to explore, understand and access clinical trials.
|
|
| Locked | Locked | Locked |
Patients for clinical trials are identified through a dedicated platform.
|
|
| Locked | Locked | Locked |
Clinical trials marketplace for patient recruitment solutions is provided.
|
|
| Locked | Locked | Locked |
AI-enabled platform sources candidates for inclusive employment of disabled individuals.
|
Detailed competitors of Evidation
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Evidation
Complete news archive for Evidation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Evidation
Evidation was founded in 2012.
Evidation is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Leslie Oley Wilberforce is the current CEO of Evidation.
Evidation is a funded company, having raised a total of $259.16M across 7 funding rounds to date.
Evidation is focused on collecting and analyzing real-world health data to support faster decisions in healthcare. Services are offered to life sciences, government, non-profit organizations, and digital health sectors. Solutions include patient cohort recontact, continuous data generation, and insights into patient experiences to improve access and outcomes. The platform integrates electronic health records, patient-reported outcomes, and social determinants of health for comprehensive research.
Evidation's top competitors include myTomorrows, Dyania Health and SubjectWell.
Evidation offers Real-World Data Platform and Patient Insights.
Evidation has 14 investors. Key investors include McKesson, General Electric, Revelation Partners, B Capital, and OMERS Private Equity.